Clorox Company (The)s in-depth stock price analysis indicates that the stock price has rallied 10.65% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -2.76% . Looking at the past 52 week period, the stock price is down -0.4% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Clorox Company (The) has a negative value of -4.79 compared to overall market performance. Clorox Company (The) (NYSE:CLX) has climbed 1.51% in the past week and advanced 6.27% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 0.69% and the outperformance has advanced to 4.37% for the last 4 weeks period.
Clorox Company (The) (NYSE:CLX) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.37 points or 0.29% at $127.03 with 1,110,272 shares getting traded. Post opening the session at $126.8, the shares hit an intraday low of $126.58 and an intraday high of $127.72 and the price was in this range throughout the day. The company has a market cap of $16,294 million and the number of outstanding shares has been calculated to be 128,265,855 shares. The 52-week high of Clorox Company (The) (NYSE:CLX) is $140.47 and the 52-week low is $111.24.
Clorox Co Last issued its quarterly earnings results on Feb 3, 2017. The company reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03. Analyst had a consensus of $1.22. The company had revenue of $1406.00 million for the quarter, compared to analysts expectations of $1407.64 million. The companys revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Clorox Co was Upgraded by Barclays on Jan 9, 2017 to Equal Weight, Lowers Price Target to $ 111 from a previous price target of $115 .Clorox Co was Upgraded by Morgan Stanley to Equal-Weight on Dec 16, 2016. Clorox Co was Resumed by Wells Fargo to Market Perform on Nov 15, 2016.
Company has reported several Insider transactions to the SEC, on Dec 2, 2016, A D David Mackay (director) purchased 5,000 shares at 114.90 per share price.On Sep 7, 2016, Laura Stein (EVP – General Counsel) sold 38,882 shares at 131.69 per share price.On Aug 31, 2016, Jon M Balousek (SVP – GM, Specialty Div) sold 5,136 shares at 131.14 per share price.
Clorox Companys business operations, represented by the aggregate of its U.S. Household Products and Canada, U.S. Specialty Products and International segments, include the production and marketing of non-durable consumer products sold primarily through grocery and other retail stores.